- Technology Management
- For Industry - Technology Available for Licensing
- Contact Technology Management
- old pages
- title page
- A Modern Approach to Wing Warp for Aircraft Control
- Treatment Of Liver Fibrosis Following Hepatic Injury By Selective Killing Of Activated Liver Stellate Cells
- Compositions and Methods for Treating and Diagnosing Hepatoma
- Vaccine Compositions and Methods That Increase Safety of Anti-Viral Vaccination Without Loss of Efficacy
- Automatic Pressure-Locking Valve Prevents CSF Loss and Herniation During Lumbar Puncture When Intracranial Pressure Is Elevated.
- Immortal Differentiated Type II Lung Epithelial Cell Line (T7)
- Human A Rapid, Reliable Bedside Diagnostic Method For Accurately Determining Feeding Tube Placement In Respiratory Tract, Stomach, Or Small Bowel Of Patients Prior to Enteral Nutrient Administration.
- Human Natural Killer Cell Line - NK 3.3:
- Factor IXa Protease Helix-330 (Region 1)
- In Vitro Method for Concerted Integration of Donor DNA Molecules Into Target DNA Using Retroviral Integrase and a Procedure for Evaluation of Donor DNA Integration.
- SRCAP: A Novel Transcription Protein Having Therapeutic Target and Diagnostic Target Product Development Potential.
- C-Terminal Binding Protein Interacting Protein (CtIP):
- Novel Anti-Coagulation Therapeutics: Agents That Effectively Inhibit Binding of Factor VIIIa (Region 3) With Factor IXa (Region 2) Without Activating Factor X.
- Genetically Modified Activated Protein C with Reduced Anticoagulant Properties
- C22: A Conditionally Immortalized Mouse Clara Cell Line
Vaccine Compositions and Methods That Increase Safety of Anti-Viral Vaccination Without Loss of Efficacy
Inventor: Mark L. Buller, Ph. D.
The administration of cidofovir or analogs of cidofovir together with a smallpox vaccine, for example the Dryvax® vaccine produced by Wyeth, has been shown to cause a decrease in the side effects of vaccination without affecting the efficacy of the vaccination. The antiviral agent and the vaccine may be administered either as an admixture in a single vaccine composition or as separate compositions that are administered substantially concurrently in any order at appropriate dosage levels.
It is envisioned that the co-administration of any antiviral agent with any live vaccine will decrease the side effects of the vaccination while maintaining or improving the efficacy of the vaccine.
Vaccination against various types of viral diseases including but not limited to Smallpox virus, variola, Influenza, Mumps, Rabies, Polio, Hepatitis A, Hepatitis B, HIV, and others.
Category: Anti-viral Vaccines
Keywords: Virus treatment, combination vaccine, vaccination
Patent: U.S. Provisional 60/576,840 (filed: June 3, 2004)
Reference Number: SLU-1023